Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Capizzi

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer|December 1, 1984
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA)P J Zekan, H B Muss, R L Capizzi, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignanciesB L Powell, H B Muss, R L Capizzi, et al.
Cancer|December 1, 1984
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA)P J Zekan, H B Muss, R L Capizzi, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
American Journal of Clinical Oncology|October 1, 1988
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association StudyB L Powell, J B Craig, H B Muss, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Pageof 13